Advertisement

Clinical Presentation of HPV-Driven Oropharyngeal Carcinoma

  • Michael MooreEmail author
  • Marion Couch
Chapter

Abstract

Due to the relatively subtle symptoms caused by lesions in the pharynx, oropharyngeal squamous cell carcinomas (OPSCC) are frequently not identified until they are at an advanced stage. Neck masses are commonly the presenting symptom, with small primary masses in the oropharynx. In addition, patients with human papilloma virus (HPV)-associated head and neck cancer have a very different set of clinicodemographic characteristics than oropharyngeal cancer associated with smoking and alcohol usage. This may lead to physicians underestimating the significance of neck masses or throat pain in this younger, healthier patient population. This chapter will review the relevant clinical epidemiology, risk factors, and patient characteristics of HPV-related oropharyngeal cancer, as well as the anatomy of the oropharynx and the adjacent structures. The typical clinical presentation and appropriate evaluation for these carcinomas will be outlined and the challenges of diagnosing these patients will be discussed. Second primaries and patterns of recurrence will be compared between HPV (+) and (−) OPSCC. And finally, the need for a revised staging system will be explored.

Keywords

Human Papilloma Virus Soft Palate Oropharyngeal Cancer Tongue Base Neck Masse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra W, Chung C, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35PubMedCentralPubMedCrossRefGoogle Scholar
  2. Bernier J, Ozsahin M, Lefebvre JL, Maingon P, Cognetti F, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. New Engl J Med 350(19):1945–1952PubMedCrossRefGoogle Scholar
  3. Candela FC, Kothari K, Shah JP (1990) Patterns of cervical node metastases from squamous carcinoma of the oropharynx and hypopharynx. Head Neck 12(3):197–203Google Scholar
  4. Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301PubMedCentralPubMedCrossRefGoogle Scholar
  5. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Choa KSC, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. New Engl J Med 350(19):1937–1944PubMedCrossRefGoogle Scholar
  6. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–56Google Scholar
  7. D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 199:1263–1269PubMedCrossRefGoogle Scholar
  8. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML (2008) Improved survival with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100(4):261–269PubMedCrossRefGoogle Scholar
  9. Ferris RL, Quon H. (2013) ECOG 3311: Phase II randomized trial of transoral surgical resection followed by low-dose or standard-dose imrt in resectable p16 + locally advanced oropharyngeal cancerGoogle Scholar
  10. Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, Lugli A, Wolfensberger M, Terracciano LM (2010) P16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 21:1961–1966PubMedCrossRefGoogle Scholar
  11. Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31:744–754PubMedCrossRefGoogle Scholar
  12. Gillison ML, D’Souza G, Westra W, Sugar E, Xiao W, Begum S et al (2008) Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 100:407–420PubMedCrossRefGoogle Scholar
  13. Haughey BH, Sinha P (2012) Prognostic factors and survival unique to p16+ oropharyngeal cancer. Laryngoscope 122(Supp 2):S13–S33PubMedCrossRefGoogle Scholar
  14. Huang SH, Perez-Ordonez B, Weinreb I, Hope A, Massey C, Waldron JN, Kim J, Bayley AJ, Cummings B, Cho BC, Ringash J, Dawson LA, Siu LL, Chen E, Irish J, Gullane P, Hui A, Lui FF, Shen X, Xu W (2013) O’Sullivan. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol 49(1):79–85PubMedCrossRefGoogle Scholar
  15. Jain KS, Sikora AG, Baxi SS, Morris LG (2013) Synchronous cancer in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer 119(10):1832–1837PubMedCrossRefGoogle Scholar
  16. Jakscha J, Zlobec I, Storck C, Obermann EC, Tornillo L et al (2013) The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 270(2):661–667PubMedCrossRefGoogle Scholar
  17. Kreimer AR, Clifford GM, Boyle P, Franceschi S (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–75Google Scholar
  18. Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JMG, D’Silva NJ, Yang K, Kurnit DM, Bradford CR, Carey TE (2007). Response to therapy and outcome in oropharyngeal cancer are associated with biomarkers including HPV, EGFR, gender and smoking. Int J Radiat Oncol Biol Phys. Oct; 69 (Supp 1): s1098–s111Google Scholar
  19. McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW (2014) Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol 50(3):208–212PubMedCrossRefGoogle Scholar
  20. McIlwain WR, Sood AJ, Nguyen SA, Day TA (2014) Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck SurgGoogle Scholar
  21. Mirghani H, Ferchiou M, Moreau F, Vourexakis Z et al (2013) Oropharyngeal cancers: significance of HPV16 detection in neck lymph nodes. J Clin Virol 57(2):120–124PubMedCrossRefGoogle Scholar
  22. Morani AC, Eisbruch A, Carey TE, Hauff SJ, Walline HM, Mukherji SK (2013) Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies. J Comput Assist Tomogr 37(3):343–345PubMedCentralPubMedCrossRefGoogle Scholar
  23. Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I (2011) Second primary cancer after index head and neck cancer: subsite specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol 29(6):739–746PubMedCentralPubMedCrossRefGoogle Scholar
  24. O’Sullivan B, Huang SH, Perez-Ordonez B (2012) Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol 103:49–56PubMedCrossRefGoogle Scholar
  25. Peck BW, Dahlstrom KR, Gan SJ, Caywood W, Li G, Wei Q, Zafereo ME, Sturgis EM (2013) Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 35(6):794–799PubMedCentralPubMedCrossRefGoogle Scholar
  26. Pitchers M, Martin C (2006) Delay in referral of oropharyngeal squamous cell carcinoma to secondary care correlates with a more advanced stage at presentation, and is associated with poorer survival. Br J Cancer 94(7):955–958PubMedCentralPubMedCrossRefGoogle Scholar
  27. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW (1991) Standardizing neck dissection terminology. Official report of the academy’s committee for head and neck surgery and oncology. Arch Otolaryngol Head Neck Surg 117(6):601–605PubMedCrossRefGoogle Scholar
  28. Robinson M, Sloan P, Shaw R (2010) Refining the diagnosis of oropharyngeal squamous cell carcinoma using human papillomavirus testing. Oral Oncol 46(7):492–496PubMedCrossRefGoogle Scholar
  29. Sedaghat AR, Zhang Z, Begum S, Palermo R, Best S, Ulmer KM, Levine M, Zinreich E, Messing BP, Gold D, Wu AA, Niparko KJ, Kowalski J, Hirata RM, Saunders JR, Westra WH, Pai SI (2009) Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope 119(8):1542–1549PubMedCrossRefGoogle Scholar
  30. Shiboski CH, Schmidt BL, Jordan RC (2005) Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20–44 years. Cancer 103:1843–1849PubMedCrossRefGoogle Scholar
  31. Sinha P, Lewis JS Jr, Piccirillo JF, Kallogjeri D, Haughey BH (2012) Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer 118(14):3519–3530PubMedCrossRefGoogle Scholar
  32. Sinha P, Thorstad WT, Nussenbaum B, Haughey BH, Adkins DR, Kallogieri D, Lewis JS Jr (2014) Distant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomes. Oral Oncol 50(1):45–51PubMedCentralPubMedCrossRefGoogle Scholar
  33. Smith DF, Maleki Z, Coughlan D, Gooi Z, Akpeng B, Ogawa T, Bishop JA, Frick KD, Agrawal N, Gourin CG, Ha PK, Koch WM, Richmon JD, Westra WH, Pai SI (2014) Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay. Oral Oncol 50(6):600–604PubMedCentralPubMedCrossRefGoogle Scholar
  34. Zhu L, Wang N (2013) 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis. Surg Oncol 22(3):190–194PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Otolaryngology—Head & Neck SurgeryIndiana University School of MedicineIndianapolisUSA

Personalised recommendations